West Family Investments’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,350
Closed -$230K 271
2022
Q1
$230K Buy
6,350
+300
+5% +$10.3K 0.07% 239
2021
Q4
$239K Sell
6,050
-2,060
-25% -$85.9K 0.07% 257
2021
Q3
$354K Buy
8,110
+1,600
+25% +$71.8K 0.09% 191
2021
Q2
$266K Buy
+6,510
New +$251K 0.07% 255

Other funds holding GMAB

West Family Investments's GMAB Position: Q2 2022 in Review

West Family Investments sold out of Genmab (GMAB) in Q2 2022, closing a stake of 6,350 shares — an estimated $230K sold.

West Family Investments first reported a position in GMAB in Q2 2021 and held it in 4 quarters. The position peaked at $354K in Q3 2021. 181 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

  • West Family Investments reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
  • West Family Investments sold 6,350 Genmab shares in Q2 2022, an estimated $230K.
  • West Family Investments first reported a position in Genmab in Q2 2021 and held it in 4 quarters.
  • West Family Investments's Genmab position peaked at $354K in Q3 2021.
  • 181 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on West Family Investments's 13F filing for Q2 2022, filed 12 Aug 2022.